micafungin

5.1:6-anhydro{(4R,5R)-4,5-dihydroxy-N²-(4-{5-[4-(pentyloxy)phenyl]isoxazol-3-yl}benzoyl)-L-ornithyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-(3S,4S)-3-hydroxy-4-methyl-L-proline}

PIEUQSKUWLMALL-YABMTYFHSA-N CHEBI:600520 0 Reactome links 1 studies

Metabolite details

Identifier: PIEUQSKUWLMALL-YABMTYFHSA-N
InChI Key: PIEUQSKUWLMALL-YABMTYFHSA-N
IUPAC name: 5.1:6-anhydro{(4R,5R)-4,5-dihydroxy-N²-(4-{5-[4-(pentyloxy)phenyl]isoxazol-3-yl}benzoyl)-L-ornithyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-(3S,4S)-3-hydroxy-4-methyl-L-proline}
Preferred name: micafungin
INN name: micafungin
Synonym: Mycamine
ChEBI: CHEBI:600520

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)

Observed in differential profiles

G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47